Propranolol inhibits EMT and metastasis in breast cancer through miR-499-5p-mediated Sox6

ConclusionThese results suggest that propranolol may have potential as a therapeutic agent for breast cancer treatment by targeting EMT and its regulatory mechanisms.

Source: Journal of Cancer Research and Clinical Oncology - January 31, 2024 Category: Cancer & Oncology Source Type: research